Literature DB >> 8243605

Emergence of oropharyngeal candidiasis caused by non-albicans species of Candida in HIV-infected patients.

F Barchiesi, V Morbiducci, F Ancarani, G Scalise.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8243605     DOI: 10.1007/bf00157408

Source DB:  PubMed          Journal:  Eur J Epidemiol        ISSN: 0393-2990            Impact factor:   8.082


× No keyword cloud information.
  4 in total

1.  Mucosal candidiasis caused by non-albicans species of Candida in HIV-positive patients.

Authors:  W G Powderly
Journal:  AIDS       Date:  1992-06       Impact factor: 4.177

2.  Candida krusei sepsis in HIV infection.

Authors:  H J Stellbrink; H Albrecht; S Fenske; K Koperski
Journal:  AIDS       Date:  1992-07       Impact factor: 4.177

3.  Fluconazole and Candida krusei fungemia.

Authors:  D A Persons; M Laughlin; D Tanner; J Perfect; J P Gockerman; J W Hathorn
Journal:  N Engl J Med       Date:  1991-10-31       Impact factor: 91.245

4.  Increase in Candida krusei infection among patients with bone marrow transplantation and neutropenia treated prophylactically with fluconazole.

Authors:  J R Wingard; W G Merz; M G Rinaldi; T R Johnson; J E Karp; R Saral
Journal:  N Engl J Med       Date:  1991-10-31       Impact factor: 91.245

  4 in total
  9 in total

1.  Prevalence and antifungal susceptibility of vaginal yeasts in outpatients attending a gynecological center in Ancona, Italy.

Authors:  D Arzeni; M Del Poeta; O Simonetti; A M Offidani; L Lamura; M Balducci; N Cester; A Giacometti; G Scalise
Journal:  Eur J Epidemiol       Date:  1997-06       Impact factor: 8.082

Review 2.  Susceptibility testing of fungi: current status of correlation of in vitro data with clinical outcome.

Authors:  M A Ghannoum; J H Rex; J N Galgiani
Journal:  J Clin Microbiol       Date:  1996-03       Impact factor: 5.948

Review 3.  Resistance of Candida species to fluconazole.

Authors:  J H Rex; M G Rinaldi; M A Pfaller
Journal:  Antimicrob Agents Chemother       Date:  1995-01       Impact factor: 5.191

4.  Oral Candida isolates colonizing or infecting human immunodeficiency virus-infected and healthy persons in Mexico.

Authors:  Luis Octavio Sánchez-Vargas; Natalia Guadalupe Ortiz-López; María Villar; María Dolores Moragues; José Manuel Aguirre; Miguel Cashat-Cruz; Jose Luis Lopez-Ribot; Luis Alberto Gaitán-Cepeda; Guillermo Quindós
Journal:  J Clin Microbiol       Date:  2005-08       Impact factor: 5.948

5.  Human defects in STAT3 promote oral mucosal fungal and bacterial dysbiosis.

Authors:  Loreto Abusleme; Patricia I Diaz; Alexandra F Freeman; Teresa Greenwell-Wild; Laurie Brenchley; Jigar V Desai; Weng-Ian Ng; Steven M Holland; Michail S Lionakis; Julia A Segre; Heidi H Kong; Niki M Moutsopoulos
Journal:  JCI Insight       Date:  2018-09-06

6.  Optimal management of oropharyngeal and esophageal candidiasis in patients living with HIV infection.

Authors:  Jose A Vazquez
Journal:  HIV AIDS (Auckl)       Date:  2010-04-28

7.  Candida glabrata Esophagitis: Are We Seeing the Emergence of a New Azole-Resistant Pathogen?

Authors:  Aze Wilson; Johan Delport; Terry Ponich
Journal:  Int J Microbiol       Date:  2014-12-03

8.  Role of posaconazole in the management of oropharyngeal and esophageal candidiasis.

Authors:  Jose A Vazquez
Journal:  Ther Clin Risk Manag       Date:  2007-08       Impact factor: 2.423

9.  Fluconazole Resistance among Oral Candida Isolates from People Living with HIV/AIDS in a Nigerian Tertiary Hospital.

Authors:  Iriagbonse I Osaigbovo; Patrick V Lofor; Rita O Oladele
Journal:  J Fungi (Basel)       Date:  2017-12-08
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.